Companies › MBIO

MUSTANG BIO INC (MBIO)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001680048 · EDGAR filings · Updated 2026-05-05

MUSTANG BIO INC (MBIO) has reported institutional ownership of 7.5%, with 22 institutional managers holding positions valued at $369.8K per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Latest updates

• 2026-05-05 — Quarterly report (10-Q) filed
• 2026-04-27 — Insider transaction reported (Form 4)
• 2026-04-17 — Current report (8-K) filed
• 2026-03-19 — Annual report (10-K) filed
• 2026-01-05 — SCHEDULE 13D/A filed
• 2026-01-05 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, MUSTANG BIO INC has 22 institutional holders and institutional ownership of 7.5%.

Insider activity

Insiders reported 7 transactions (1 buys, 2 sells) across 5 reporting insiders, with a net reported value of −$4.

Data flags from SEC filings

Related companies

Theriva Biologics Inc (TOVX) · SILO PHARMA INC (SILO) · NEXALIN TECHNOLOGY INC (NXL) · ACLARION INC (ACON) · Aspire Biopharma Holdings Inc (ASBP) · ALAUNOS THERAPEUTICS INC (TCRT)